Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered
in the Netherlands, today announces the following management appointments:

Gerard de Reuver (1956) at present Business Group Director DSM Anti Infectives (DAI), will be appointed Director Strategic Projects as per 1 March 2009, reporting to F. Sijbesma, Chairman of the DSM Managing Board. Gerard will be responsible for coordination and support of the program addressing the current economic circumstances and DSM's change agenda.

Stefan Doboczky (1967) at present Business Unit Director DAI China, will succeed Gerard de Reuver as Business Group Director DAI as of 1 March 2009. Stefan has held various other management positions within the Pharma cluster before he joined DAI. He will report to Jan Zuidam, Deputy Chairman of the DSM Managing Board.

DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. DSM has annual sales of almost EUR 8.8 billion and employs some 23,000 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com